Berberin, an isoquinolien alkaloid of barberry, lowers blood glucose and lipid concentrations;Berberin, ein isochinolinalkaloid der berberitze, mit blutglukose- und -lipidsenkender wirkung

Ernahrungs Umschau

Volumn 54, Issue 10, 2007, Pages 570-573

  Schmandke, Horst ^a  

^a Bergholz Rehbrücke ^*  (Germany)

Author keywords

Berberine; Diabetes mellitus type II; Hyperlipidemia; Lowering of blood fats; Lowering of the blood glucose concentration

Indexed keywords

BERBERIDACEAE; BERBERIS; COPTIS; COPTIS CHINENSIS; HYDRASTIS; HYDRASTIS CANADENSIS; PHELLODENDRON AMURENSE; THALICTRUM;

EID: 35948969879     PISSN: 01740008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Cho E (1990) Berberine hydrochloride. Pharmacopoeia of the People's Republic of China 2; 437-439
2. Iizuka N et al. (2000) Inhibitory effect of Coptidis rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett 148; 19-25
3. Iizuka N et al. (2002) Anticachetic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma. Int J Cancer 99; 286-291
4. Asai M et al. (2007) Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease A-β secretion. Biochem Biophys Res Com 352; 498-502
5. Yu C et al. (2000) Determination and preliminary studies of metabolism of berberine in human urine after oral administration. Chin J Clin Pharmacol 16; 36-39
6. Chen C-M, Chang H-C (1995) Determination of berberine in plasma, urine and bile by high-performance liquid chromatography. J Chromatogr B 665; 117-123
7. Schein FT, Calvin H (1960) The absorption, distribution and excretion of berberine. Arch Int Pharmacodyn 124; 317-325
8. Zuo F et al. (2006) Pharmacokinetics of berberine and its main metabolites in convential and pseudo germ-free rats determined by Liquid Chromatography/Ion Trap Mass Spectrometry. Drug Metab Dispos 34; 2064-2072
9. Tsai P-L, Tsai T-H (2004) Hepatobiliary excretion of berberine. Drug Metab Dispos 32; 405-412
10. Pan J-F et al. (2002) Identification of three sulfate-conjugated metabolites of berberine chloride in healthy volunteers ' urine after oral administration. Acta Pharmacol Sin 23; 77-82
11. Bhide MB et al. (1969) Absorption, distribution and excretion of berberine. Ind J Med Res 57; 2128-2131
12. Wang X et al. (2005) Pharmacokinetics of berberine in rat thalamus after intravenous administration of Coptidis rhizoma extract. Am J Chin Med 3; 935-943
13. Leng S-H et al. (2004) Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol Sin 25; 496-502
14. Brusq J-M et al. (2006) Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. J Lipid Res 47; 1281-1288
15. Kong W et al. (2004) Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10 (2004) 1344-1351
16. Yin J et al. (2002) Effects of berberine on glucose metabolism in vitro. Metabolism 51; 1439-1443
17. Zhou L et al. (2007) Berberine stimulates transport through a mechanism distinct from insulin. Metab Clin Exp 56; 405-412
18. Huang C et al. (2006) Berberine inhbits 3T3-L1 adipocyte differentiation through the PPAR gamma pathway. Biochem Biophys Res Commun 348; 571-578